In this edition of The Motley Fool's health care show, Market Checkup, analysts David Williamson and Max Macaluso take a close look at two of the most prominent potential turnaround stories in the pharmaceutical space: generic drugmaker Teva and struggling giant AstraZeneca.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.